Author

Yi Xiao

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Advances in CAR-T and CAR-NK cell therapy in follicular lymphoma: a review.

Follicular lymphoma (FL) is the most common indolent B-cell non-Hodgkin lymphoma and is characterized by prolonged survival but recurrent relapses. The unmet need is greatest among patients with high-risk disease, including progression of disease within 24 months of first-line immunochemotherapy (POD24), double-refract...

Si-Jia Yan, Wan-Ying Liu, Mi Zhou et al. · Transplantation and Cellular... · 0 citations

Review Open access Sep 2026

Beyond Remission: Risk-Adapted Maintenance and Mechanism-Guided Salvage After CAR T-Cell Therapy for Multiple Myeloma.

BACKGROUND B-cell maturation antigen (BCMA)-directed chimeric antigen receptor (CAR) T-cell therapy can induce deep responses in relapsed or refractory multiple myeloma, yet relapse remains frequent. Neither post-infusion maintenance nor salvage after CAR T-cell failure has an established standard. MAIN TEXT This rev...

Shuai-Xi Su, Si-Jia Yan, Jia-Ying Wu et al. · Stem Cell Reviews and Report... · 0 citations